Casdin Partners Master Fund, L.P., Director, 10% Owner at STANDARD BIOTOOLS INC. (LAB), bought 100,000 shares at $1.29 ($129K) on 2025-09-09, disclosed to the SEC on 2025-09-11.
Open-market purchase of $129k LAB by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| LAB | BUY | 2025-08-26 | $658K | — | Filing → |
| WGS | BUY | 2024-03-06 | $358K | — | Filing → |
| BLFS | BUY | 2023-05-18 | $2.2M | — | Filing → |